These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 11313164)

  • 1. Short-term efficacy of tricyclic antidepressants revisited: a meta-analytic study.
    Storosum JG; Elferink AJ; van Zwieten BJ; van den Brink W; Gersons BP; van Strik R; Broekmans AW
    Eur Neuropsychopharmacol; 2001 Apr; 11(2):173-80. PubMed ID: 11313164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural course and placebo response in short-term, placebo-controlled studies in major depression: a meta-analysis of published and non-published studies.
    Storosum JG; Elferink AJ; van Zwieten BJ; van den Brink W; Huyser J
    Pharmacopsychiatry; 2004 Jan; 37(1):32-6. PubMed ID: 14750046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious features.
    Tollefson GD; Holman SL; Sayler ME; Potvin JH
    J Clin Psychiatry; 1994 Feb; 55(2):50-9. PubMed ID: 8077155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination therapy using moclobemide with tricyclic and tetracyclic antidepressants to treat therapy-resistant depression.
    König F; Wolfersdorf M
    Pharmacopsychiatry; 1997 May; 30(3):93-6. PubMed ID: 9211570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of mirtazapine versus citalopram: a double-blind, randomized study in patients with major depressive disorder. Nordic Antidepressant Study Group.
    Leinonen E; Skarstein J; Behnke K; Agren H; Helsdingen JT
    Int Clin Psychopharmacol; 1999 Nov; 14(6):329-37. PubMed ID: 10565799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression.
    Beasley CM; Dornseif BE; Bosomworth JC; Sayler ME; Rampey AH; Heiligenstein JH; Thompson VL; Murphy DJ; Masica DN
    BMJ; 1991 Sep; 303(6804):685-92. PubMed ID: 1833012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antidepressants consumption in the global population in France].
    Olié JP; Elomari F; Spadone C; Lépine JP
    Encephale; 2002; 28(5 Pt 1):411-7. PubMed ID: 12386542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. St. John's wort for depression: a meta-analysis of well-defined clinical trials.
    Kim HL; Streltzer J; Goebert D
    J Nerv Ment Dis; 1999 Sep; 187(9):532-8. PubMed ID: 10496508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lithium and desipramine versus desipramine alone in the treatment of severe major depression: a preliminary study.
    Cappiello A; McDougle CJ; Delgado PL; Malison RT; Jatlow P; Charney DS; Heninger GR; Price LH
    Int Clin Psychopharmacol; 1998 Sep; 13(5):191-8. PubMed ID: 9817623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amitriptyline versus placebo for major depressive disorder.
    Leucht C; Huhn M; Leucht S
    Cochrane Database Syst Rev; 2012 Dec; 12(12):CD009138. PubMed ID: 23235671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A placebo-controlled comparison of lithium and triiodothyronine augmentation of tricyclic antidepressants in unipolar refractory depression.
    Joffe RT; Singer W; Levitt AJ; MacDonald C
    Arch Gen Psychiatry; 1993 May; 50(5):387-93. PubMed ID: 8489327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mirtazapine versus amitriptyline in the long-term treatment of depression: a double-blind placebo-controlled study.
    Montgomery SA; Reimitz PE; Zivkov M
    Int Clin Psychopharmacol; 1998 Mar; 13(2):63-73. PubMed ID: 9669186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind randomized comparison of nortriptyline plus perphenazine versus nortriptyline plus placebo in the treatment of psychotic depression in late life.
    Mulsant BH; Sweet RA; Rosen J; Pollock BG; Zubenko GS; Flynn T; Begley AE; Mazumdar S; Reynolds CF
    J Clin Psychiatry; 2001 Aug; 62(8):597-604. PubMed ID: 11561930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tricyclic nonresponders: phenomenology and treatment.
    Roose SP; Glassman AH; Walsh BT; Woodring S
    Am J Psychiatry; 1986 Mar; 143(3):345-8. PubMed ID: 3953869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does thyroid supplementation accelerate tricyclic antidepressant response? A review and meta-analysis of the literature.
    Altshuler LL; Bauer M; Frye MA; Gitlin MJ; Mintz J; Szuba MP; Leight KL; Whybrow PC
    Am J Psychiatry; 2001 Oct; 158(10):1617-22. PubMed ID: 11578993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs.
    Peet M; Horrobin DF
    Arch Gen Psychiatry; 2002 Oct; 59(10):913-9. PubMed ID: 12365878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis of placebo-controlled trials with mirtazapine using the core items of the Hamilton Depression Scale as evidence of a pure antidepressive effect in the short-term treatment of major depression.
    Bech P
    Int J Neuropsychopharmacol; 2001 Dec; 4(4):337-45. PubMed ID: 11806859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moclobemide--placebo-controlled trials.
    Silverstone T
    Int Clin Psychopharmacol; 1993 Jan; 7(3-4):133-6. PubMed ID: 8468433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bupropion in tricyclic antidepressant nonresponders with unipolar major depressive disorder.
    Ferguson J; Cunningham L; Merideth C; Apter J; Feighner J; Ionescu-Pioggia M; Samara B; Johnston JA; Ascher J
    Ann Clin Psychiatry; 1994 Sep; 6(3):153-60. PubMed ID: 7881495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A risk-benefit assessment of mirtazapine in the treatment of depression.
    Kasper S; Praschak-Rieder N; Tauscher J; Wolf R
    Drug Saf; 1997 Oct; 17(4):251-64. PubMed ID: 9352961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.